文献速递哮喘

系统生物学与大数据在哮喘和过敏研究中的发现与挑战

Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges.
PubMed 文献 · Eur Respir J · 2020-01-09

该综述概述了系统生物学方法在过敏和哮喘研究中的应用,描述了近期组学层面发现及系统性整合以生成新见解,指出过敏由遗传、表观遗传与环境因素共同驱动导致免疫发育紊乱,机器学习用于探索异质性与内型,数学模型基于组学数据预测疾病表型,系统医学有望实现更精准的哮喘管理。

要点

  • 过敏由遗传、表观遗传与环境因素(微生物组、饮食)共同驱动早期免疫发育紊乱。
  • 机器学习用于探索哮喘和过敏的异质性,识别与亚表型相关的病理生理模式或内型。
  • 基于基因组、转录组和蛋白质组数据的数学模型可预测或区分疾病表型。

核心结论

  • 系统生物学在过敏和哮喘研究中应用迅速增长并已取得丰硕成果,但伴随规模和多学科性质带来的新挑战。
  • 系统医学将组学数据整合入临床实践,有望实现更精准、个性化和有效的哮喘管理。

研究设计与样本

  • 综述类:概述系统生物学方法在过敏和哮喘研究中的应用,描述近期组学层面发现并检查其系统性整合以生成进一步见解。

主要发现

  • 过敏由遗传和表观遗传因素与环境因素(如微生物组和饮食)共同驱动,导致生命早期免疫发育 disturbance 和关键免疫炎症通路平衡破坏。
  • 遗传易感性和暴露的变异导致哮喘和其他过敏性疾病表现的异质性。
  • 机器学习方法正被用于探索这种异质性,并探究与哮喘和过敏亚表型相关的病理生理模式或内型。
  • 正在构建基于基因组、转录组和蛋白质组数据的数学模型,以预测或区分疾病表型,并描述哮喘背后的生物分子网络。

临床怎么用

  • 系统医学将组学数据整合入临床实践,可推动哮喘的更精准、个性化和有效管理。

局限性

  • 系统生物学研究的规模和多学科性质伴随新的挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma is a common condition caused by immune and respiratory dysfunction, and it is often linked to allergy. A systems perspective may prove helpful in unravelling the complexity of asthma and allergy. Our aim is to give an overview of systems biology approaches used in allergy and asthma research. Specifically, we describe recent "omic"-level findings, and examine how these findings have been systematically integrated to generate further insight.Current research suggests that allergy is driven by genetic and epigenetic factors, in concert with environmental factors such as microbiome and diet, leading to early-life disturbance in immunological development and disruption of balance within key immuno-inflammatory pathways. Variation in inherited susceptibility and exposures causes heterogeneity in manifestations of asthma and other allergic diseases. Machine learning approaches are being used to explore this heterogeneity, and to probe the pathophysiological patterns or "endotypes" that correlate with subphenotypes of asthma and allergy. Mathematical models are being built based on genomic, transcriptomic and proteomic data to predict or discriminate disease phenotypes, and to describe the biomolecular networks behind asthma.The use of systems biology in allergy and asthma research is rapidly growing, and has so far yielded fruitful results. However, the scale and multidisciplinary nature of this research means that it is accompanied by new challenges. Ultimately, it is hoped that systems medicine, with its integration of omics data into clinical practice, can pave the way to more precise, personalised and effective management of asthma.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Tang HHF, Sly PD, Holt PG, et al. Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges. Eur Respir J. 2020. PMID: 31619470. doi:10.1183/13993003.00844-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。